UBE2G1

gene product
UBC7, UBE2G
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family and catalyzes the covalent attachment of ubiquitin to other proteins. The protein may be involved in degradation of muscle-specific proteins. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Knockdown Initiative

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated in Knockdown Initative
Eligible for validation in KDI
130 antibodies from 20 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeKDWBELICCIPIHCFC
antibodies-online
41 antibodies
Abnova Corporation
4 antibodies
Proteintech Group
1 antibody
Novus Biologicals
6 antibodies
Acris Antibodies GmbH
6 antibodies
Atlas Antibodies
2 antibodies
Invitrogen Antibodies
2 antibodies
Abgent
4 antibodies
Aviva Systems Biology
3 antibodies
GeneTex
1 antibody
LifeSpan BioSciences, Inc.
20 antibodies
RabMAbs
1 antibody
Biorbyt
3 antibodies
MyBioSource
4 antibodies
St John's Laboratory
2 antibodies
RayBiotech, Inc.
1 antibody
Sigma-Aldrich
2 antibodies
Creative Diagnostics
2 antibodies
United States Biological
13 antibodies